A proteogenomic surfaceome study identifies DLK1 as an immunotherapeutic target in neuroblastoma
Title:
A proteogenomic surfaceome study identifies DLK1 as an immunotherapeutic target in neuroblastoma
Author:
Hamilton, Amber K. Radaoui, Alexander B. Tsang, Matthew Martinez, Daniel Conkrite, Karina L. Patel, Khushbu Sidoli, Simone Delaidelli, Alberto Modi, Apexa Rokita, Jo Lynne Lane, Maria V. Hartnett, Nicholas Lopez, Raphael D. Zhang, Bo Zhong, Chuwei Ennis, Brian Miller, Daniel P. Brown, Miguel A. Rathi, Komal S. Raman, Pichai Pogoriler, Jennifer Bhatti, Tricia Pawel, Bruce Glisovic-Aplenc, Tina Teicher, Beverly Erickson, Stephen W. Earley, Eric J. Bosse, Kristopher R. Sorensen, Poul H. Krytska, Kateryna Mosse, Yael P. Havenith, Karin E. Zammarchi, Francesca van Berkel, Patrick H. Smith, Malcolm A. Garcia, Benjamin A. Maris, John M. Diskin, Sharon J.